„Die Kosten für eine mögliche Einigung müssen die Steuerzahler tragen, da AstraZeneca in der Hochphase von Covid einen Entschädigungsvertrag mit der Regierung geschlossen hat, um die Impf-Dosen so schnell wie möglich zu produzieren.“
„Die Kosten für eine mögliche Einigung müssen die Steuerzahler tragen, da AstraZeneca in der Hochphase von Covid einen Entschädigungsvertrag mit der Regierung geschlossen hat, um die Impf-Dosen so schnell wie möglich zu produzieren.“
To pay the bills, Mr. Durov is issuing investors $1 billion to $1.5 billion of company debt, with the promise of discounted equity if the company eventually goes public, the people briefed on the plans said. He has also announced plans to start selling ads in public Telegram channels as soon as later this year, as well as offering other premium services for businesses and users.
At a time when the Indian stock market is peaking and has rallied immensely compared to global markets, there are companies that have not performed in the last 10 years. These are definitely a minor portion of the market considering there are hundreds of stocks that have turned multibagger since 2020. What went wrong with these stocks? Reasons vary from corporate governance, sectoral weakness, company specific and so on. But the more important question is, are these stocks worth buying?
